Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P377: Serum adalimumab trough levels required for mucosal healing during maintenance therapy in patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

H. Imaeda*, Y. Morita, T. Fujimoto, K. Takahashi, M. Shioya, A. Nishida, O. Inatomi, S. Bamba, M. Sasaki, T. Tsujikawa, M. Sugimoto, A. Andoh

Shiga University of Medical Science, Department of Medicine, Otsu, Japan

P378: The outcomes of a clinical care pathway for inflammatory bowel disease surgeryECCO '16 Amsterdam
Year: 2016
Authors:

A. Platt*1, A. Lightner2, R. Jacobs1, D. Sagar1, W. van Deen1, T. Hommes1, S. Reardon3, J. Sack3, D. Hommes1

1UCLA Centre for Inflammatory Bowel Diseases, Department of Digestive Diseases, Los Angeles, California, United States, 2Mayo Clinic College of Medicine, Division of Colon and Rectal Surgery, Rochester, Minnesota, United States, 3UCLA, Department of Colorectal Surgery, Los Angeles, California, United States

P379: Inflammatory bowel disease-induced chronic abdominal pain can be ameliorated by transcranial direct current stimulationECCO '16 Amsterdam
Year: 2016
Authors:

M. S. Prüß*, A. Farmer, B. Siegmund

Charité - University Hospital Berlin, Campus Benjamin Franklin, Department of Gastroenterology, Berlin, Germany

P380: Comparative study of infliximab and adalimumab induction therapy for clinical remission and mucosal healing in paediatric patients with active Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

E. Szymanska*1, M. Dadalski2, S. Szymanska3, W. Grajkowska3, M. Pronicki3, K. Jaroslaw2

1Children’s Memorial Health Institute, Department of Paediatrics, Nutrition and Metabolic Disorders, Warsaw, Poland, 2Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology and Feeding Disorders, Warsaw, Poland, 3Children’s Memorial Heath Institute, Department of Pathology, Warsaw, Poland

P381: An observational study of adverse events of patients with inflammatory bowel disease receiving parenteral ironECCO '16 Amsterdam
Year: 2016
Authors:

A. Wilson*, E. Murray, G. B. Turner

Belfast Trust, Belfast, United Kingdom

P382: Comparison of efficacy and safety of biosimilar infliximab to originator infliximab in children with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

R. Muhammed*, L. Whyte, S. Protheroe, R. Bremner, W. Haller, T. Wong

Birmingham Children’s Hospital, Gastroenterology, Birmingham, United Kingdom

P383: Short- and long-term outcomes of infliximab and calcineurin inhibitor treatment for steroid-refractory ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

S. Motoya*, M. Miyakawa, M. Nasuno, H. Tanaka

Sapporo-Kosei General Hospital, IBD Centre, Sapporo, HOKKAIDO, Japan

P384: The usefulness of salazosulfapyridine for 
patients with ulcerative colitis refractory to mesalazineECCO '16 Amsterdam
Year: 2016
Authors:

T. Yoshino*, S. Yazumi

Kitano Hospital, Division of Gastroenterology and Hepatology, Digestive Disease Centre, Osaka, Japan

P385: Predictors of tissue healing in ulcerative colitis patients treated with anti-TNFECCO '16 Amsterdam
Year: 2016
Authors:

N. Viazis*1, M. Giakoumis1, G. Bamias2, D. Goukos2, T. Koukouratos1, J. Anastasiou1, K. Katopodi1, S. Ladas2, D. Karamanolis1

1Evangelismos Hospital, Gastroenterology Department, Athens, Greece, 2Kapodistrian University of Athens, Laikon Hospital, Academic Department of Gastroenterology, Athens, Greece

P386: Anti-TNF alpha as induction and maintenance therapy in ulcerative colitis patients in the BioColitis Registry in GermanyECCO '16 Amsterdam
Year: 2016
Authors:

B. Bokemeyer*1, T. Krummenerl2, C. Maaser3, J. Büning4, R. Atreya5, A. Lügering6, U. Helwig7, P. Jessen8, P. Hartmann9, S. Schreiber10

1Gastroenterology Practice Minden, University Hospital Schleswig-Holstein, Department of General Internal Medicine I, Kiel, Germany, Minden, Germany, 2Gastroenterology Practice, Gastroenterology, Münster, Germany, 3University Teaching Hospital Lüneburg, IBD Outpatient Clinic and Department of Geriatric Medicine, Lüneburg, Germany, 4University Hospital Schleswig-Holstein, Campus Lübeck, Medical Department I, Gastroenterology, Lübeck, Germany, 5University of Erlangen-Nuremberg, Department of Medicine 1, Erlangen, Germany, 6Gastroenterology Practice Münster, Münster, Germany, 7Gastroenterology Practice Oldenburg, Oldenburg, Germany, 8Gastroenterology Practice, Gastroenterology, Altenholz, Germany, 9Gastroenterology Practice, Minden, Germany, 10Christian-Albrechts-Universität, University Hospital Schleswig-Holstein, Department of General Internal Medicine I, Kiel, Germany

P387: Does standard therapy in paediatric Crohn’s disease really prevent our patients from the need of early initiation of anti-TNF treatment?ECCO '16 Amsterdam
Year: 2016
Authors:

P. Domínguez Sánchez*, G. Pujol Muncunill, S. Pinillos Pison, V. Vila Miravet, J. Martín de Carpi

Unit for the Comprehensive Care of Paediatric Inflammatory Bowel Disease. Department of Paediatric Gastroenterology, Hepatology and Nutrition. Hospital Sant Joan de Déu, Barcelona, Spain

P388: Clinical care pathways are needed to decrease variability in the management of the hospitalised ulcerative colitis patientECCO '16 Amsterdam
Year: 2016
Authors:

S. Shah*, S. Naymagon, B. Cohen, B. Sands, M. Dubinsky

Mount Sinai Hospital, Gastroenterology, New York, New York, United States

P389: The value of oxidative stress parameters to predict histological severity in ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

B. Canbakan*1, K. Atay1, E. Koroglu1, M. Tuncer1, H. Senturk2

1Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey, 2Bezmialem University School of Medicine, Gastroenterology, Istanbul, Turkey

P390: To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohortECCO '16 Amsterdam
Year: 2016
Authors:

B. Huggett*, S. Sider, S. Chadokufa, N. Acton, N. Shah, F. Kiparissi

Great Ormond Street Hospital, London, United Kingdom

P391: Gender differences in adalimumab continuation rates: Results of a Crohn’s disease cohortECCO '16 Amsterdam
Year: 2016
Authors:

M. Lie*, J. Kreijne, J. van der Woude

Erasmus MC, Gastroenterology and Hepatology, Rotterdam, Netherlands

P392: Comparing the accuracy and ease of use of self-administered ‘Malnutrition Universal Screening Tool’ (MUST) to screening by a health care professional using MUST to explore malnutrition rates in an outpatient inflammatory bowel disease clinicECCO '16 Amsterdam
Year: 2016
Authors:

S. Zacharopoulou-Otapasidou*1, K. Keetarut1, S. Bloom2, S. McCartney2

1University College London Hospital, Nutrition and Dietetics Department, London, United Kingdom, 2University College London Hospital, Department of Gastroenterology, London, United Kingdom

P393: Investigation of Crohn’s disease patients receiving anti-TNF α therapy after surgery for intestinal stenosisECCO '16 Amsterdam
Year: 2016
Authors:

T. Kuriyama*, B. Iizuka, H. Kashiwagi, T. Hara, A. Ito, T. Omori, M. Yonezawa, K. Tokushige

Tokyo Women’s Medical University, Gastroenterology, Tokyo, Japan

P394: Psychosexual dysfunction in a cohort of Greek inflammatory bowel disease patients in clinical remission: preliminary resultsECCO '16 Amsterdam
Year: 2016
Authors:

D. Xanthis*, K. Soufleris, E. Gavalas, P. Anyfanti, G. Chatzinakos, N. Grammatikos, A. Tsimperidis, O. Giouleme

Aristotle University of Thessaloniki, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece

P395: Real-life prospective experience with adalimumab in ulcerative colitis in Italy: preliminary results of a pilot studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Daperno*1, A. Armuzzi2, D. Pugliese2, A. Lavagna1, P. Gionchetti3, F. Rizzello3

1AO Ordine Mauriziano, Gastroenterology Unit, Torino, Italy, 2Complesso Integrato Columbus, Internal Medicine, Roma, Italy, 3AO S. Orsola-Malpighi & University, Internal Medicine, Bologna, Italy

P396: Cyclosporin A efficacy in a paediatric ulcerative colitis: a retrospective single-centre studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Osiecki*, M. Dadalski, J. Kierkus

The Children’s Memorial Health Institute, Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland